Edition:
United States

Kangmei Pharmaceutical Co Ltd (600518.SS)

600518.SS on Shanghai Stock Exchange

21.55CNY
18 Dec 2017
Change (% chg)

¥0.01 (+0.05%)
Prev Close
¥21.54
Open
¥21.42
Day's High
¥21.60
Day's Low
¥20.94
Volume
15,378,631
Avg. Vol
19,522,408
52-wk High
¥23.90
52-wk Low
¥16.95

Latest Key Developments (Source: Significant Developments)

Kangmei Pharmaceutical to invest 47.5 mln yuan to set up genetic tech JV in Shenzhen
Thursday, 7 Dec 2017 11:00pm EST 

Dec 8(Reuters) - Kangmei Pharmaceutical Co Ltd <600518.SS>:Says it plans to invest 47.5 million yuan to set up a genetic technology JV with BGI Genomics Co Ltd <<<300676.SZ>>>, with registered capital of 50 million yuan, in Shenzhen .Says the company will hold a 95 percent stake in the JV .  Full Article

Kangmei Pharmaceutical's controlling shareholder issues 2017 second tranche exchangeable bonds worth 3 bln yuan
Sunday, 3 Dec 2017 05:11am EST 

Dec 3(Reuters) - Kangmei Pharmaceutical Co Ltd <600518.SS>:Says its controlling shareholder issues 2017 second tranche non-public exchangeable bonds worth 3 billion yuan, with a term of three years .  Full Article

Kangmei Pharmaceutical signs strategic cooperation agreement with local government
Tuesday, 21 Nov 2017 06:40am EST 

Nov 21(Reuters) - Kangmei Pharmaceutical Co Ltd <600518.SS>:Says it signs strategic cooperation agreement with local government of Dingxi city, Gansu province.Says two entities will cooperate on medicine related business .  Full Article

Kangmei Pharmaceutical says controlling shareholder issues 2017 1st tranche non-public exchangeable bonds worth 2 bln yuan
Wednesday, 8 Nov 2017 01:42am EST 

Nov 8(Reuters) - Kangmei Pharmaceutical Co Ltd <600518.SS>:Says co's controlling shareholder, an industry investment firm, issued 2017 first tranche non-public exchangeable bonds worth 2 billion yuan, with term of 3 years.  Full Article

Kangmei Pharmaceutical to sell 100 pct stake in Weihai-based bioengineering firm for 2.2 mln yuan
Monday, 30 Oct 2017 04:37am EDT 

Oct 30(Reuters) - Kangmei Pharmaceutical Co Ltd <600518.SS> ::Says it plans to sell 100 percent stake in a Weihai-based bioengineering firm for 2.2 million yuan .  Full Article

Kangmei Pharmaceutical's 9-month profit up, to invest in three units and acquire a firm
Friday, 27 Oct 2017 09:13am EDT 

Oct 27 (Reuters) - Kangmei Pharmaceutical Co Ltd <600518.SS>:Says 9-month net profit up 21.6 percent y/y.Says it plans to invest 160 million yuan ($24.05 million) to set up three units.Says it plans to acquire pharmaceutical firm for up to 140 million yuan.  Full Article

Kangmei Pharmaceutical issues 2017 third tranche mid-term bills worth 2 bln yuan
Monday, 18 Sep 2017 11:28pm EDT 

Sept 19 (Reuters) - Kangmei Pharmaceutical Co Ltd <600518.SS>:* Says it issued 2017 third tranche mid-term bills worth 2 billion yuan with a term of 5 years, and coupon rate of 5.47 percent .* China Construction Bank served as the main underwriter.  Full Article

Kangmei Pharmaceutical adopts new accounting policies
Tuesday, 29 Aug 2017 12:56am EDT 

Aug 29 (Reuters) - Kangmei Pharmaceutical Co Ltd <600518.SS> ::* Says it adopts new accounting policies regarding government subsidy, and non-current assets, disposal group and discontinued operations .  Full Article

Kangmei Pharmaceutical unit plans two 80-pct-owned medical equipment JVs with partner
Tuesday, 29 Aug 2017 12:55am EDT 

Aug 29 (Reuters) - Kangmei Pharmaceutical Co Ltd <600518.SS> ::* Says its unit plans to invest totaling 16 million yuan to set up two medical equipment JVs with partner, and will own a 80 percent stake in JVs respectively.  Full Article

Kangmei Pharmaceutical unit to buy medical sci-tech firm for 1.8 mln yuan
Tuesday, 29 Aug 2017 12:46am EDT 

Aug 29 (Reuters) - Kangmei Pharmaceutical Co Ltd <600518.SS> ::* Says its wholly owned pharma subsidiary plans to fully acquire a Hainan-based medical sci-tech firm for about 1.8 million yuan.  Full Article

BRIEF-Kangmei Pharmaceutical in deal to invest 5 bln yuan in Guizhou

* SAYS IT SIGNS STRATEGIC AGREEMENT TO INVEST 5.0 BILLION YUAN ($756.06 million) IN GUIZHOU ON AREAS INCLUDING CHINESE MEDICINE RESEARCH, HEALTH BIG DATA Source text in Chinese: http://bit.ly/2Avc4TM Further company coverage: ($1 = 6.6132 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)